Juva Life Announces Webinar Takeaways, Showcasing Increased Production, Operational Milestones and Pharmaceutical Advances

Content of the article

Cannabis and Life Sciences Webinar Highlights Milestones, Growth and Future Plans

VANCOUVER, British Columbia, March 24, 2022 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life”, “Juva” or the “Company”), a life sciences company with pharmaceutical research and development and consumer-facing cannabis production and distribution, today announced the successful completion of the company’s update webinar, which shared the dishes to take away and updates on pharmaceutical development from its research division.

Advertisement 2

Content of the article

“We are continually refining our processes to make Juva the most profitable and efficient company in the cannabis and pharmaceutical industries,” said Doug Chloupek, CEO and Founder of Juva. “One of our major updates that you will see in this webinar is the completion of the construction of our Stockton cultivation facility, which has tripled our production, without increasing base production costs. We are also delighted to share major advances with our two proprietary compounds, JUVA-019 and JUVA-041.”

The company’s webinar was originally broadcast live on Zoom on March 23, 2022 and featured updates and progress on the company’s build. The webinar also provided an update on its cannabis and pharmaceutical operations. Webinar viewers were able to see updates on:

Advertisement 3

Content of the article

  • Juva’s newly completed Stockton cultivation facility, which had previously been under construction for 3.5 years
  • Operational milestones such as Stockton Delivery which is now fully online and operational
  • Completion of final phase of licensing for downtown retail store in Redwood City
  • Accelerated R&D on the pharmaceutical side of Juva, achieved at a fraction of the cost of traditional pharmaceutical research
  • The newly revised JuLi Research Registry, which has just received WIRB approval

Those interested in viewing the webinar recording can do so here: https://juvalife.com/investors/

ON BEHALF OF COUNCIL,

-Doug Chloupek-

Doug Chloupek, CEO and Founder

Juva Life Inc.

requests@juvalife.com

About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (ENG: 4VV)

Advertisement 4

Content of the article

Juva Life uses cutting-edge science to discover, develop and market safe and effective pharmaceutical and wellness products, both in the cannabis consumer segment and in the non-cannabinoid medical industry. The company is successfully executing on its 2018 roadmap, initially starting with the standardization of cultivation, extraction and formulation to deliver repeatable benefits to consumers. Juva is building on these skills in natural product process chemistry, to now include discovery pharmacology. The Company will leverage revenues from its retail operations to advance its clinical and consumer development efforts of Juva-019 and Juva-041, as well as other potentially valuable non-cannabinoid bioactives with important applications in consumer products and pharmaceuticals. Juva strives to challenge the cannabis market with the industry’s investment-grade, next-generation business model. Learn more about:
https://juvalife.com/.

Advertisement 5

Content of the article

For more information, please contact:

Juva Life Investor Relations

Phone : +1 833-333-5882 (JUVA)

E-mail: requests@juvalife.com

Forward-looking statement

This press release contains statements and information which, to the extent that they are not historical facts, may constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may include financial and other projections, as well as statements regarding future economic plans, objectives or performance, or assumptions underlying any of the foregoing. In some instances, forward-looking statements may be identified by words such as “may”, “would”, “could”, “will”, “likely”, “unless”, “anticipate”, “believe”, “have the ‘intention’, ‘plan’, ‘forecast’, ‘project’, ‘estimate’, ‘prospect’, or their negative form or other similar expressions relating to matters which are not historical facts. Examples of such statements include, but are not limited to, statements regarding the Company’s objectives and business plans; product development, marketing strategy and future collaborations.

Advertising 6

Content of the article

Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the information. forward-looking, including, without limitation, risks related to the Company’s future business plans; the risks that the Company may not be able to retain its key personnel; the risks that the Company may not be able to obtain financing on reasonable terms or at all, as well as all other risks described in the Company’s management report for the financial year ended December 31, 2020 under the section “Risks and uncertainties”. Accordingly, readers should not place undue reliance on such forward-looking information. Further, any forward-looking information speaks only as of the date such statement is made. New factors appear from time to time and it is not possible for the management of the Company to foresee all of these factors and to assess in advance the impact of each of these factors on the activities of the Company or the the extent to which any factor, or combination of factors, could cause actual results to differ materially from those contained in the forward-looking information. The Company undertakes no obligation to update forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unforeseen events, except as required by law, including securities laws.

CSE does not accept responsibility for the adequacy or accuracy of this release.

Advertising

comments

Postmedia is committed to maintaining a lively yet civil discussion forum and encourages all readers to share their views on our articles. Comments can take up to an hour to be moderated before appearing on the site. We ask that you keep your comments relevant and respectful. We have enabled email notifications. You will now receive an email if you receive a reply to your comment, if there is an update to a comment thread you follow, or if a user follows you comments. See our Community Guidelines for more information and details on how to adjust your email settings.

Comments are closed.